Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: The experience at children's memorial hospital

Journal of Clinical Oncology

Volumn 22, Issue 14, 2004, Pages 2885-2890

  Campbell, Andrew D ^a   Cohn, Susan L ^a   Reynolds, Marleta ^a   Seshadri, Roopa ^a   Morgan, Elaine ^a   Geissler, Grant ^a   Rademaker, Alfred ^a   Marymount, Maryann ^a   Kalapurakal, John ^a   Haut, Paul R ^a   Duerst, Reggie ^a   Kletzel, Morris ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; MELPHALAN; THIOTEPA; ANTINEOPLASTIC AGENT; ETOPOSIDE;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; HUMAN; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE COUNT; ADOLESCENT; AUTOTRANSPLANTATION; CHILD; DOSE RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFANT; KIDNEY TUMOR; MALE; METHODOLOGY; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; MELPHALAN; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; THIOTEPA; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WILMS TUMOR;

EID: 4344642234     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.09.073     Document Type: Article

References (19)

1. Green DM, Thomas PR, Schochats S, et al: The treatment of Wilms' tumor: Results of the National Wilms' Tumor Studies. Hematol Oncol Clin North Am 9:1267-1274, 1995
2. Grundy P, Breslow N, Green DM, et al: Prognostic factors for children with recurrent Wilms' Tumor: Results from the Second and Third National Wilms' Tumor Study. J Clin Oncol 7:638-647, 1989
3. Abu-Ghosh AM, Krailo MD, Goldman SC, et al: Ifosfamide, carboplatin, and etoposide in children with poor-risk relapsed Wilms' tumor: A Children's Cancer Group report. Ann Oncol 13:460-469, 2002
4. Kung FH, Berstein ML, Camitta BM, et al: Ifosfamide/carboplatin/etoposide (ICE) in the treatment of advanced, recurrent Wilms' tumor. Proc Am Soc Clin Oncol 17:2156, 1999 (abstr 2156)
5. Pein F, Tournade MF, Zucker JM, et al: Etoposide and carboplatin: Highly effective combination in relapsed or refractory Wilms' tumor - A phase II study by the French Society of Pediatric Oncology. J Clin Oncol 12:931-936, 1994
6. De Camargo B, Melargno R, Saba e Silva N, et al: Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: Experience of the Brazilian Wilms' Tumor Study Group. Med Pediatr Oncol 22:258-260, 1994
7. Malogolowkin M, Feusner J, Steele DA, et al: Carboplatin/etoposide for the treatment of children with high risk or recurrent Wilms' tumor. Proc Am Soc Clin Oncol 13:424, 1994 (abstr)
8. Miser J, Krailo M, Hammond GD, et al: The combination of ifosfamide, etoposide, and MESNA: A very active regimen in the treatment of recurrent Wilms' tumor. Proc Am Soc Clin Oncol 12:417, 1993 (abstr)
9. Garaventa A, Hartmann O, Benard JL, et al: Autologous bone marrow transplantation for pediatric Wilms' tumor: The experience of the European Bone Marrow Transplantation Solid Tumor Registry. Med Pediatr Oncol 22:11-14, 1994
10. Kletzel M, Morgan E, Cohn SL, et al: Autologous bone marrow (BM)/peripheral blood stem cell rescue in children with relapsed Wilms' tumor (WT). Proc Am Soc Clin Oncol 12:414, 1993 (abstr 1451)
11. Pein F, Michon J, Valteau-Couanet D, et al: High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: A French Society of Pediatric Oncology Study. J Clin Oncol 16:3295-3301, 1998
12. Saarinen-Pihkala UM, Wikstrom S, Vettenranta K, et al: Maximal preservation of renal function in patients with bilateral Wilms' tumor: Therapeutic strategy of late kidney-sparing surgery and replacement of radiotherapy by high-dose melphalan and stem cell rescue. Bone Marrow Transplant 22:53-59, 1998
13. Maurer K, Heitger A, Schwaighofer H, et al: Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor. Bone Marrow Transplant 20:1111-1113, 1997
14. Perentesis JP, Katsanis E, DeFor TE, et al: Autologous stem cell transplantation for high-risk pediatric solid tumors. Bone Marrow Transplant 24:609-615, 1999
15. Dagher R, Kreissman S, Robertson K, et al: High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms' tumor. J Pediatr Hematol Oncol 20:357-360, 1998
16. Kletzel M, Kim AR: Autologous bone marrow transplantation in pediatric solid tumors. Blood Stem Cell Transplant 334-351, 1997
17. Kremens B, Gruhn B, Klingebiel T, et al: High-dose chemotherapy with autologous stem rescue in children with nephroblastoma. Bone Marrow Transplant 30:893-898, 2002
18. Malogolowkin M, Bergman T, Seibel N, et al: Outcome and prognostic factors for patients with recurrent Wilms' tumor: National Wilms' Tumor Study 3 and 4. Proc Am Soc Clin Oncol 19:3236, 2001 (abstr 3136)
19. Green DM, Breslow NE, Beckwith JB, et al: Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 16:237-245, 1998